Mpox disease is caused by a double-stranded DNA virus, genus Orthopoxvirus of the family Poxviridae. The incubation period is usually 6 to 13 days but can range from 5 to 21 days while symptoms and signs may persist for 2 to 5 weeks. Although, the clinical features are usually less severe when compared to the deadly smallpox, the disease can be fatal with case fatality rate between 1% and 10%. In Imo State, Nigeria, there has been a changing epidemiology of the disease in the last 6 years and the frequency and geographic distribution of cases have progressively increased. This study aims to conduct a review of the disease epidemiology between 2017 and 2023 and implications for surveillance in Imo State. Surveillance data from the Surveillance Outbreak Response and Management System (SORMAS) was extracted between January 2017 and December 2023 across the 27 Local Government Areas (LGAs) of Imo State. A line list of 231 suspected cases was downloaded into an excel template and analyzed using SPSS® version 20 software. Analysis was done using descriptive statistics and associations were tested using Fischer’s exact at 0.05 level of significance. Of the 231 suspected cases, 57.1% (132) were males, 42.9% (99) were females and the modal age group was between the ages of 0 - 4 (32.5%). Eight (8) LGAs (districts) accounted for 71% (n = 164) of all the suspected cases. 21.2% (49) were confirmed positive, 27 males (55.1%) and 22 females (44.9%) (p > 0.05). Modal age group was 20 - 24 (22.4%, n = 11), 18% (9) were children under 14 years, p > 0.05. Case fatality rate was 8% (n = 4). There was no significant association between mortality and age group. Five (5) LGAs accounted for about 60% (29) of all confirmed cases. These LGAs contribute only 20% to the total population in the State. Only 5.6% and 4% of suspected and confirmed cases, respectively, had knowledge of contact with an infectious source. The study described the epidemiology of Mpox outbreaks between 2017 and 2023 and the findings have significant implications on detection and outbreak response activities.
References
[1]
Petersen, E., Kantele, A., Koopmans, M., et al. (2019) Human Monkeypox Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Clinical Infectious Diseases, 33, 1027-1043. https://doi.org/10.1016/j.idc.2019.03.001
[2]
Osadebe, L., Hughes, C.M., Shongo Lushima, R., Kabamba, J., Nguete, B., Malekani, J., et al. (2017) Enhancing Case Definitions for Surveillance of Human Monkeypox in the Democratic Republic of Congo. PLOS Neglected Tropical Diseases, 11, E0005857. https://doi.org/10.1371/journal.pntd.0005857
[3]
Marennikova, S.S., Šeluhina, E.M., Mal’Ceva, N.N., Čimiškjan, K.L. and Macevič, G.R. (1972) Isolation and Properties of the Causal Agent of a New Variola-Like Disease (Monkeypox) in Man. Bulletin of the World Health Organization, 46, 599-611. https://apps.who.int/iris/handle/10665/263482
[4]
WHO (2022) Monkeypox Outbreak: Update and Advice for Health Workers (Issue May).
[5]
Di Giulio, D.B. and Eckburg, P.B. (2004) Human Monkeypox: An Emerging Zoonosis. The Lancet Infectious Diseases, 4, 15-25. https://doi.org/10.1016/S1473-3099(03)00856-9
[6]
Jezek, Z., Grab, B., Szczeniowski, M.V., Paluku, K.M. and Mutombo, M. (1988) Human Monkeypox: Secondary Attack Rates. Bulletin of the World Health Organization, 66, 465-470.
[7]
Hutin, Y.J., Williams, R.J., Malfait, P., Pebody, R., Loparev, V.N., Ropp, S.L., Rodriguez, M., Knight, J.C., Tshioko, F.K., Khan, A.S., Szczeniowski, M.V. and Esposito, J.J. (2001) Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerging Infectious Diseases, 7, 434-438. https://doi.org/10.3201/eid0703.017311
[8]
Jezek, Z., Szczeniowski, M., Paluku, K.M. and Mutombo, M. (1988) Human Monkeypox: Confusion with Chickenpox. Acta Tropica, 45, 297-307. https://pubmed.ncbi.nlm.nih.gov/2907258/
[9]
Jezek, Z., Arita, I., Mutombo, M., Dunn, C. and Nakano, J.H. (1986) Four Generations of Probable Person-to-Person Transmission of Human Monkeypox. American Journal of Epidemiology, 123, 1004-1012. https://doi.org/10.1093/oxfordjournals.aje.a114328
[10]
Ichihashi, Y. and Oie, M. (1987) Epitope Mosaic on the Surface Proteins of Orthopoxviruses. Virology, 163, 133-144. https://doi.org/10.1016/0042-6822(88)90240-1
[11]
Fine, P.E., Jezek, Z., Grab, B., et al. (1988) The Transmission Potential of Monkeypox Virus in Human Populations. International Journal of Epidemiology, 17, 654-650. https://doi.org/10.1093/ije/17.3.643
[12]
Petersena, E., Abubakar, I., Ihekweazu, C., et al. (2018) Monkeypox—Enhancing Public Health Preparedness for an Emerging Lethal Human Zoonotic Epidemic Threat in the Wake of the Smallpox Post-Eradication Era. International Journal of Infectious Diseases, 78, 78-84. https://www.elsevier.com/locate/ijid https://doi.org/10.1016/j.ijid.2018.11.008
[13]
Gromyko, A.I. and Daramola, M. (1979) Results of an Investigation of a Case of Monkeypox in Nigeria [French]. World Health Organization, Geneva.
[14]
Eteng, W.E., Mandra, A., Doty, J., Yinka-Ogunleye, A., Aruna, S., et al. (2018) Notes From the Field: Responding to an Outbreak of Monkeypox Using the One Health Approach—Nigeria, 2017-2018. Morbidity and Mortality Weekly Report (MMWR), 67, 1040-10411. https://doi.org/10.15585/mmwr.mm6737a5
[15]
Elsevier Monkeypox Information Center (2018) Genomic Characterisation of Human Monkeypox Virus in Nigeria. Elsevier, Amsterdam, S1473-3099(18), 30043-30044.
[16]
Quiner, C.A., Moses, C., Monroe, B.P., Nakazawa, Y., Doty, J.B., Hughes, C.M., Mccollum, A.M., Ibata, S., Malekani, J., Okitolonda, E., Carroll, D.S. and Reynolds, M.G. (2017) Presumptive Risk Factors for Monkeypox in Rural Communities in the Democratic Republic of the Congo. PLOS ONE, 12, e0168664. https://doi.org/10.1371/journal.pone.0168664
[17]
Bunge, E.M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., et al. (2022) The Changing Epidemiology of Human Monkeypox—A Potential Threat? A Systematic Review. PLOS Neglected Tropical Diseases, 16, e0010141. https://doi.org/10.1371/journal.pntd.0010141
[18]
Hoff, N.A., Doshi, R.H., Colwell, B., Kebela-Illunga, B., Mukadi, P., Mossoko, M., et al. (2017) Evolution of a Disease Surveillance System: An Increase in Reporting of Human Monkeypox Disease in the Democratic Republic of the Congo, 2001-2013. International Journal of Tropical Disease & Health, 25, 1-10. https://doi.org/10.9734/IJTDH/2017/35885
[19]
Austin-Egole, I.S., Iheriohanma, E.B.J., Iheanacho, J.I., Ezeji, N.R., Okafor, H.I. and Wokoma, C.U. (2022) Insecurity and the Pauperization of Residents of Owerri in Imo State, Nigeria: An Empirical Assessment. European Journal of Social Sciences Studies, 7, 36-61. https://doi.org/10.46827/ejsss.v7i3.1232
[20]
Kumbhar, N. and Agarwala, P. (2022) The Lurking Threat of Monkeypox in Current Times. Indian Journal of Medical Microbiology, 40, 475-479. https://doi.org/10.1016/j.ijmmb.2022.07.016
[21]
Nigeria Centre for and Control, D. (2019) National Monkeypox Public Health Response Guidelines. Federal Ministry of Health, Abuja, Nigeria.
[22]
Durski, K.N., McCollum, A.M., Nakazawa, Y., Petersen, B.W., Reynolds, M.G., et al. (2018) Emergence of Monkeypox—West and Central Africa, 1970-2017. MMWR Morbidity and Mortality Weekly Report, 67, 306-310. https://doi.org/10.15585/mmwr.mm6710a5
